BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2014 11:02:00 AM | Browse: 1111 | Download: 1107
 |
Received |
|
2013-11-16 11:18 |
 |
Peer-Review Started |
|
2013-11-17 08:17 |
 |
To Make the First Decision |
|
2014-01-09 15:35 |
 |
Return for Revision |
|
2014-01-20 09:15 |
 |
Revised |
|
|
 |
Second Decision |
|
2014-03-06 17:52 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-03-06 18:17 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-03-11 08:41 |
 |
Publish the Manuscript Online |
|
2014-03-27 12:04 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Autobiography |
Article Title |
Cortactin expression confers a more malignant phenotype to gastric cancer SGC-7901 cells
|
Manuscript Source |
Invited Manuscript |
All Author List |
Jun Wei, Zhong-Xin Zhao, Yang Li, Zhu-Qing Zhou and Tian-Geng You |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Project of Shanghai Science and Technology Commission of China |
10411968400 |
|
Corresponding Author |
Tian-Geng You, PhD, Department of Gastroenterological Surgery, Shanghai East Hospital, Tongji University School of Medicine, Jimo Rd 150, Shanghai 200120, China. tiangengyou2003@163.com |
Key Words |
Gastric cancer; Cortactin; Epidermal growth factor receptor; Invasion; Metastasis; Proliferation |
Core Tip |
Cortactin is an actin-related protein 2/3 complex-activating and filamentous (F)-actin-binding protein that is implicated in tumor cell motility and metastasis. Clinical studies have shown that cortactin overexpression is often associated with the clinicopathological parameters and poor prognosis in a variety of cancers, including gastric cancer. In this study, the effects of cortactin on gastric cancer progression were investigated. The results showed that cortactin expression promoted SGC-7901 cell migration, invasion and proliferation both in vitro and in vivo. The epidermal growth factor receptor signaling pathway is mechanistically involved. Cortactin may serve as a novel therapeutic target of gastric cancer. |
Publish Date |
2014-03-27 12:04 |
Citation |
Wei J, Zhao ZX, Li Y, Zhou ZQ, You TG. Cortactin expression confers a more malignant phenotype to gastric cancer SGC-7901 cells. World J Gastroenterol 2014; 20(12): 3287-3300 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i12/3287.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i12.3287 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345